156 related articles for article (PubMed ID: 11142413)
1. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.
Calaluce R; Earnest DL; Heddens D; Einspahr JG; Roe D; Bogert CL; Marshall JR; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1287-92. PubMed ID: 11142413
[TBL] [Abstract][Full Text] [Related]
2. Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.
Chow HH; Earnest DL; Clark D; Mason-Liddil N; Kramer CB; Einspahr JG; Guillen-Rodriguez JM; Roe DJ; Malone W; Crowell JA; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):351-6. PubMed ID: 10794478
[TBL] [Abstract][Full Text] [Related]
3. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
Alberts DS; Einspahr J; Ritenbaugh C; Aickin M; Rees-McGee S; Atwood J; Emerson S; Mason-Liddil N; Bettinger L; Patel J; Bellapravalu S; Ramanujam PS; Phelps J; Clark L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):161-9. PubMed ID: 9138658
[TBL] [Abstract][Full Text] [Related]
4. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
[TBL] [Abstract][Full Text] [Related]
6. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
8. [Nonsteroidal anti-inflammatory drugs and the risk of polyposis, colon carcinoma and rectal carcinoma].
Gao X; Sun S; Sun F; Li M; Sun H; Zhang W; Song S
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Sep; 36(5):332-5. PubMed ID: 12411196
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
10. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa.
Holt PR; Bresalier RS; Ma CK; Liu KF; Lipkin M; Byrd JC; Yang K
Cancer; 2006 Jan; 106(2):287-96. PubMed ID: 16353199
[TBL] [Abstract][Full Text] [Related]
11. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
[TBL] [Abstract][Full Text] [Related]
12. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa.
MartÃnez ME; Heddens D; Earnest DL; Bogert CL; Roe D; Einspahr J; Marshall JR; Alberts DS
J Natl Cancer Inst; 1999 Jun; 91(11):950-3. PubMed ID: 10359547
[TBL] [Abstract][Full Text] [Related]
13. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME
Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
16. Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls.
Nair S; Norkus EP; Hertan H; Pitchumoni CS
Am J Gastroenterol; 2001 Dec; 96(12):3400-5. PubMed ID: 11774956
[TBL] [Abstract][Full Text] [Related]
17. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.
Thompson PA; Wertheim BC; Zell JA; Chen WP; McLaren CE; LaFleur BJ; Meyskens FL; Gerner EW
Gastroenterology; 2010 Sep; 139(3):797-805, 805.e1. PubMed ID: 20538001
[TBL] [Abstract][Full Text] [Related]
18. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.
Matsuhashi N; Nakajima A; Shinohara K; Oka T; Yazaki Y
Am J Gastroenterol; 1998 Nov; 93(11):2261-6. PubMed ID: 9820411
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas.
Martin C; Connelly A; Keku TO; Mountcastle SB; Galanko J; Woosley JT; Schliebe B; Lund PK; Sandler RS
Gastroenterology; 2002 Dec; 123(6):1770-7. PubMed ID: 12454832
[TBL] [Abstract][Full Text] [Related]
20. Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study.
Finley PR; Bogert CL; Alberts DS; Einspahr J; Earnest DL; Blackwell G; Girodias K
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):239-44. PubMed ID: 7606198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
